跳至主要内容
临床试验/NCT01145144
NCT01145144已完成不适用

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Meir Medical Center2 个研究点 分布在 1 个国家开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
2
主要终点
peak estradiol level.

研究概览

简要总结

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • previous poor response to ovarian stimulation in IVF.

排除标准

  • patients over the age of 42
  • patients who received DHEA at any time.

研究组 & 干预措施

DHEA supplementation

Experimental

DHEA was added to induction of ovulation by recombinant FSH and recombinant LH, in IVF long protocol

干预措施: dehydroepiandrosterone crystalline fine powder (Drug)

结局指标

主要结局

peak estradiol level.

number of retrieved oocytes.

Embryos that were graded as a top quality (according to the number of cells and percent of fragmentation)

number of embryos reserved for transfer.

次要结局

  • pregnancy rate.
  • live birth rate.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验